Skip to main content
. 2020 Oct 31;32(5):631–644. doi: 10.21147/j.issn.1000-9604.2020.05.08

1. Patient characteristics.

Variable Before PSM After PSM
Non-T2DM
group
(n=1,621)
T2DM
group
(n=71)
Statistic P Non-T2DM
group
(n=139)
T2DM
group
(n=71)
Statistic P
HBsAg, hepatitis B surface antigen; PSM, propensity score matching; T2DM, type 2 diabetes mellitus.
Sex 0.407 0.899
 Male 1,088 (67.1) 51 (71.8) 0.686 101 (72.7) 51 (71.8) 0.016
 Female 533 (32.9) 20 (28.2) 38 (27.3) 20 (28.2)
Age (year) 0.001 0.767
 <40 187 (11.5) 1 (1.4) −0.318 2 (1.4) 1 (1.4) −0.296
 40−69 1,249 (77.1) 56 (78.9) 112 (80.6) 56 (78.9)
 ≥70 185 (11.4) 14 (19.7) 25 (18.0) 14 (19.7)
Hepatitis 0.904 0.672
 No 1,535 (94.7) 67 (94.4) 0.015 133 (95.7) 67 (94.4) 0.180
 Yes 86 (5.3) 4 (5.6) 6 (4.3) 4 (5.6)
HBsAg (+) 0.792 0.491
 No 1,517 (93.6) 67 (94.4) 0.070 134 (96.4) 67 (94.4) 0.475
 Yes 104 (6.4) 4 (5.6) 5 (3.6) 4 (5.6)
Tumor location 0.187 0.487
 Upper 275 (17.0) 18 (25.4) 3.357 30 (21.6) 18 (25.4) 1.437
 Middle 345 (21.3) 14 (19.7) 21 (15.1) 14 (19.7)
 Lower 1,001 (61.8) 39 (54.9) 88 (63.3) 39 (54.9)
Ascites 0.977 0.324
 No 1,531 (94.4) 67 (94.4) 0.001 135 (97.1) 67 (94.4) 0.974
 Yes 90 (5.6) 4 (5.6) 4 (2.9) 4 (5.6)
Gastrectomy 0.861 0.905
 Total 500 (30.8) 24 (33.8) 0.298 43 (30.9) 24 (33.8) 0.199
 Proximal 112 (6.9) 5 (7.0) 11 (7.9) 5 (7.0)
 Distal 1,009 (62.2) 42 (59.2) 85 (61.2) 42 (59.2)
Reconstruction 0.391 0.470
 Roux-en-Y 515 (31.8) 26 (36.6) 0.735 44 (31.7) 26 (36.6) 0.521
 Others 1,106 (68.2) 45 (63.4) 95 (68.3) 45 (63.4)
Lymphadenectomy 0.689 0.917
 Non-D2/D2+ 233 (14.4) 9 (12.7) 0.160 15 (10.8) 8 (11.3) 0.011
 D2/D2+ 1,388 (85.6) 62 (87.3) 124 (89.2) 63 (88.7)
Radical resection 0.516 0.842
 Yes 1,296 (80.0) 59 (83.1) 0.423 117 (84.2) 59 (83.1) 0.040
 No 325 (20.0) 12 (16.9) 22 (15.8) 12 (16.9)
Approach 0.300 0.922
 Open/Conversion 671 (41.4) 25 (35.2) 1.074 48 (34.5) 25 (35.2) 0.010
 Laparoscopy 950 (58.6) 46 (64.8) 91 (65.5) 46 (64.8)
Receiv adjuvant chemotherapy 0.720 0.824
 No 924 (57.0) 42 (59.2) 0.129 80 (57.6) 42 (59.2) 0.049
 Yes 697 (43.0) 29 (40.8) 59 (42.4) 29 (40.8)
Histology 0.058 0.010
 Signet-ring cell 332 (20.5) 8 (11.3) 3.596 37 (26.6) 8 (11.3) 6.578
 Others 1,289 (79.5) 63 (88.7) 102 (73.4) 63 (88.7)
Grade 0.938 0.639
 G1−G2 340 (21.0) 15 (21.1) 0.127 29 (20.9) 15 (21.1) 0.896
 G3−G4 1,097 (67.7) 47 (66.2) 98 (70.5) 47 (66.2)
 Unknown 184 (11.4) 9 (12.7) 12 (8.6) 9 (12.7)
Vascular invasion 0.454 0.321
 No 1,356 (83.7) 57 (80.3) 0.561 119 (85.6) 57 (80.3) 0.984
 Yes 265 (16.3) 14 (19.7) 20 (14.4) 14 (19.7)
Neural invasion 0.217 0.422
 No 1,245 (76.8) 59 (83.1) 1.525 109 (78.4) 59 (83.1) 0.644
 Yes 376 (23.2) 12 (16.9) 30 (21.6) 12 (16.9)
Lymphatic vessel invasion 0.503 0.721
 No 1,414 (87.2) 60 (84.5) 0.449 120 (86.3) 60 (84.5) 0.128
 Yes 207 (12.8) 11 (15.5) 19 (13.7) 11 (15.5)
Primary tumor invasion 0.860 0.814
 T1 287 (17.7) 16 (22.5) −0.176 32 (23.0) 16 (22.5) −0.236
 T2 138 (8.5) 4 (5.6) 7 (5.0) 4 (5.6)
 T3 112 (6.9) 3 (4.2) 9 (6.5) 3 (4.2)
 T4 1,084 (66.9) 48 (67.6) 91 (65.5) 48 (67.6)
Lymph node status 0.571 0.667
 N0 609 (37.6) 24 (33.8) −0.566 50 (36.0) 24 (33.8) −0.430
 N1 260 (16.0) 13 (18.3) 26 (18.7) 13 (18.3)
 N2 316 (19.5) 13 (18.3) 26 (18.7) 13 (18.3)
 N3 436 (26.9) 21 (29.6) 37 (26.6) 21 (29.6)
Metastasis 0.550 0.662
 No 1,398 (86.2) 63 (88.7) 0.358 126 (90.6) 63 (88.7) 0.192
 Yes 223 (13.8) 8 (11.3) 13 (9.4) 8 (11.3)
Tumor size (cm) 0.481 0.568
 <5 981 (60.5) 40 (56.3) 0.497 84 (60.4) 40 (56.3) 0.326
 ≥5 640 (39.5) 31 (43.7) 55 (39.6) 31 (43.7)